Schedule 13G ownership disclosure
VISTAGEN THERAPEUTICS INC
Security class unavailable · CUSIP: 92840H202
Event date: 2020-01-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,614,602
- Percent of class
- 9.6200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-007804
- Form type
- SC 13G
- Filer
- Lincoln Park Capital Fund, LLC
- CIK
- CIK 1592644
- Filed
- Jan 29, 2020
- Reporting period
- Jan 24, 2020
- Description
- Schedule 13G beneficial ownership